{
  "version": 3,
  "sources": ["ssg:https://framerusercontent.com/modules/RuRznjpQhtJhjrGirquV/4JqVkHrXgRejBVF3wuMf/MVT5OSS8s.js"],
  "sourcesContent": ["// Generated by Framer (5eef525)\nexport default function metadata(params,activeLocale){return{bodyClassName:\"framer-body-MVT5OSS8s\",breakpoints:[{hash:\"1skdsmq\",mediaQuery:\"(min-width: 1200px)\"},{hash:\"12t1j7r\",mediaQuery:\"(min-width: 810px) and (max-width: 1199px)\"},{hash:\"qb9lh2\",mediaQuery:\"(max-width: 809px)\"}],description:\"This guide serves as an overview of a new clinical study for Tune-401 \u2013 the first approach to the treatment of chronic Hepatitis B Virus infection that incorporates epigenetic editing technology.\",elements:{},framerSearch:{index:true},robots:\"max-image-preview:large\",serializationId:\"framer-uZFt7\",title:\"Clinical Study Guide for HBV Patients \u2014\\xa0Tune Therapeutics\",viewport:\"width=device-width\"};}export const metadataVersion=1;\nexport const __FramerMetadata__ = {\"exports\":{\"metadataVersion\":{\"type\":\"variable\",\"annotations\":{\"framerContractVersion\":\"1\"}},\"default\":{\"type\":\"function\",\"annotations\":{\"framerContractVersion\":\"1\"}},\"__FramerMetadata__\":{\"type\":\"variable\"}}}"],
  "mappings": "AACe,SAARA,EAA0BC,EAAOC,EAAa,CAAC,MAAM,CAAC,cAAc,wBAAwB,YAAY,CAAC,CAAC,KAAK,UAAU,WAAW,qBAAqB,EAAE,CAAC,KAAK,UAAU,WAAW,4CAA4C,EAAE,CAAC,KAAK,SAAS,WAAW,oBAAoB,CAAC,EAAE,YAAY,2MAAsM,SAAS,CAAC,EAAE,aAAa,CAAC,MAAM,EAAI,EAAE,OAAO,0BAA0B,gBAAgB,eAAe,MAAM,oEAA+D,SAAS,oBAAoB,CAAE,CAAQ,IAAMC,EAAgB,EACzsBC,EAAqB,CAAC,QAAU,CAAC,gBAAkB,CAAC,KAAO,WAAW,YAAc,CAAC,sBAAwB,GAAG,CAAC,EAAE,QAAU,CAAC,KAAO,WAAW,YAAc,CAAC,sBAAwB,GAAG,CAAC,EAAE,mBAAqB,CAAC,KAAO,UAAU,CAAC,CAAC",
  "names": ["metadata", "params", "activeLocale", "metadataVersion", "__FramerMetadata__"]
}
